Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q3

4078.TEDINET S100Q2X8
Period2022-04-01 → 2022-12-31
Filed2023-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥63.8bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥59.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥4.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥6.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥4.7bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥5.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥7.5bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥5.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥131.3bnat 2022-12-31Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥123.6bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥45.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥85.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥81.1bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥207.792022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.312022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥315.692021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.842021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio62.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.6%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-12-31¥58.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥57.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥575m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥5.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥233m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥394m
—segment totalrevenue2022-04-01 → 2022-12-31¥64.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥63.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥808m
—segment totalsegment profit2022-04-01 → 2022-12-31¥5.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥1.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-12-31¥54.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-12-31¥53.4bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥765m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-12-31¥7.1bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥258m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥454m
—segment totalrevenue2021-04-01 → 2021-12-31¥60.6bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥59.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥1.0bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥7.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 378
ItemContextValueUnit
Remeasurements of defined benefit plansPrior1YearInstant21000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant21000000JPY
Valuation and translation adjustmentsPrior1YearInstant1081000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant1542000000JPY
Non controlling interestsPrior1YearInstant3854000000JPY
Non controlling interestsCurrentQuarterInstant4271000000JPY
Net assetsPrior1YearInstant82708000000JPY
Net assetsCurrentQuarterInstant85695000000JPY
Liabilities and net assetsPrior1YearInstant123919000000JPY
Liabilities and net assetsCurrentQuarterInstant131288000000JPY
Net salesPrior1YTDDuration59623000000JPY
Net salesCurrentYTDDuration63759000000JPY
Cost of salesPrior1YTDDuration43534000000JPY
Cost of salesCurrentYTDDuration48967000000JPY
Gross profitPrior1YTDDuration16089000000JPY
Gross profitCurrentYTDDuration14792000000JPY
Selling general and administrative expensesPrior1YTDDuration10059000000JPY
Selling general and administrative expensesCurrentYTDDuration10609000000JPY
Operating incomePrior1YTDDuration6030000000JPY
Operating incomeCurrentYTDDuration4182000000JPY
Interest income noiPrior1YTDDuration6000000JPY
Interest income noiCurrentYTDDuration3000000JPY
Dividends income noiPrior1YTDDuration215000000JPY
Dividends income noiCurrentYTDDuration141000000JPY
Foreign exchange gains noiPrior1YTDDuration247000000JPY
Foreign exchange gains noiCurrentYTDDuration403000000JPY
Other noiPrior1YTDDuration139000000JPY
Other noiCurrentYTDDuration60000000JPY
Non operating incomePrior1YTDDuration608000000JPY
Non operating incomeCurrentYTDDuration608000000JPY
Interest expenses noePrior1YTDDuration58000000JPY
Interest expenses noeCurrentYTDDuration55000000JPY
Other noePrior1YTDDuration77000000JPY
Other noeCurrentYTDDuration45000000JPY
Non operating expensesPrior1YTDDuration136000000JPY
Non operating expensesCurrentYTDDuration101000000JPY
Ordinary incomePrior1YTDDuration6502000000JPY
Ordinary incomeCurrentYTDDuration4689000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration29000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration4000000JPY
Gain on sales of investment securities eiPrior1YTDDuration1481000000JPY
Gain on sales of investment securities eiCurrentYTDDuration85000000JPY
Gain on sales of golf memberships eiPrior1YTDDuration－JPY
Gain on sales of golf memberships eiCurrentYTDDuration1000000JPY
Insurance income eiPrior1YTDDuration－JPY
Insurance income eiCurrentYTDDuration378000000JPY
Extraordinary incomePrior1YTDDuration1510000000JPY
Extraordinary incomeCurrentYTDDuration470000000JPY
Loss on explosion and fire accident elPrior1YTDDuration182000000JPY
Loss on explosion and fire accident elCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass